Fenosup 160mg

Fenosup 160mg

Category: Drug Info

Specifications
Details

Manufacturer:
SMB Technology S.A., Belgium

Registraction Number:
MAL12095052AZ
 

Content:

  • Each capsule contains Fenofibrate 160mg in Lidose form (improves absorption).

Indications:

  • Treatment of primary hypercholesterolemia or mixed dyslipidemia (Types IIa, IIb, III, IV, V) in adults not responsive to dietary measures alone.

  • Management of secondary hyperlipidemia, including lipid disorders associated with diabetes mellitus.

Instructions :

  • Take one 160mg capsule once daily, with food.

  • Swallow whole; do not crush or chew the capsule.

  • Continue with a low-fat, low-cholesterol diet during treatment.


View more about Fenosup 160mg on main site